Chiron may get $115 million as Roche settles IP (intellectual property) dispute
This article was originally published in Clinica
Executive Summary
The seven-year battle over intellectual property rights to probe-based diagnostics between Roche Diagnostics and Chiron has ended - in part, at least. Roche is to pay up to $115 million to license the rights to manufacture and sell probe-based tests for HCV and HIV.
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.